This invention relates to novel quinazolinone derivatives having medical utility, to use of the quinazolinone derivatives of the invention for the manufacture of a medicament, to pharmaceutical compositions comprising the quinazolinone derivatives of the invention, and to methods of treating a disorder, disease or a condition of a subject, which disorder, disease or condition is responsive to activation of K
v
7 channels.
该发明涉及具有医学用途的新型
喹唑啉酮衍
生物,涉及使用发明中的
喹唑啉酮衍
生物制造药物,涉及包括发明中的
喹唑啉酮衍
生物的制药组合物,以及涉及治疗对Kv7通道激活响应的主体的疾病,疾病或状况的方法。